Report ID: SQMIG35A2624
Report ID:
SQMIG35A2624 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
94 |
Figures:
76
Global Tracheostomy Products Market size was valued at USD 193.8 million in 2022 and is poised to grow from USD 210 million in 2023 to USD 290 million by 2031, at a CAGR of 4.2% during the forecast period (2024-2031).
The demand for tracheostomy accessories is rising as more surgeries are performed globally. COPD is one of the top causes of death in the globe. According to the WHO, there were over 251 million COPD sufferers globally. The growing number of surgeries and medical procedures that require airway management and ventilation support boosts the demand for tracheostomy products. Tracheostomy is often performed during critical care, emergency situations, and surgical procedures, creating a consistent demand for related products.
A rise in the prevalence of COPD and a consequent rise in the need for tracheostomy care are mostly caused by an increase in cigarette use and poor air quality, especially in middle-income countries. The number of persons requiring mechanical ventilation along with additional forms of respiratory support has considerably grown as a result of the COVID-19 epidemic. Long-term mechanical breathing is required for these patients, but some of them also need tracheostomies to enable weaning and make better use of hospital resources. However, because of the creation of aerosols and the high danger of nosocomial illness to medical personnel, the tracheostomy technique is challenging to conduct. Although cutaneous tracheostomy (PCT) is the gold standard of care in many ICUs, it poses a greater risk of aerosol production.
However, the main function of tracheostomies is to facilitate weaning in COVID-19 patients. Due to rising healthcare expenses and the financial standing of nations including the U.S., China, & India, among others, market participants might anticipate attractive opportunities. Additionally, tracheostomy supplies are used in numerous tracheostomy procedures, including those treating obstructive sleep apnea, chronic lung illness, anaphylaxis, throat malignancy, diaphragm malfunction, laryngectomy, and vocal cord weakness, among other conditions. The market is anticipated to rise due to favorable reimbursement policies, a developing healthcare infrastructure, and a high prevalence of respiratory illnesses.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2624